Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines

Go back to Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.53 +0.07 (2.85%)
Previous Close $2.46    52 Week High $3.64 
Open $2.50    52 Week Low $0.14 
Day High $2.60    P/E N/A 
Day Low $2.46    EPS $0.00 
Volume 56,691